Katsuyasu Saigo

2.5k total citations · 1 hit paper
106 papers, 1.8k citations indexed

About

Katsuyasu Saigo is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Katsuyasu Saigo has authored 106 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 28 papers in Genetics and 21 papers in Molecular Biology. Recurrent topics in Katsuyasu Saigo's work include Platelet Disorders and Treatments (18 papers), Acute Myeloid Leukemia Research (17 papers) and Hemoglobinopathies and Related Disorders (10 papers). Katsuyasu Saigo is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Acute Myeloid Leukemia Research (17 papers) and Hemoglobinopathies and Related Disorders (10 papers). Katsuyasu Saigo collaborates with scholars based in Japan, United States and Nigeria. Katsuyasu Saigo's co-authors include Shunichi Kumagai, Seiji Kawano, Kunihiro Nishimura, Goh Tsuji, Akio Morinobu, M. Koshiba, Takashi Nakazawa, Isao Kamae, Daisuke Sugiyama and Yoshinori Kogata and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Katsuyasu Saigo

105 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis

2007 587 citations Seiji Kawano, Katsuyasu Saigo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katsuyasu Saigo Japan	20	609	521	380	346	247	106	1.8k
Elliott B. Grossbard United States	22	493 0.8×	465 0.9×	337 0.9×	823 2.4×	522 2.1×	32	2.1k
Jonathan S. Coblyn United States	21	466 0.8×	1.2k 2.4×	199 0.5×	443 1.3×	368 1.5×	34	2.1k
H. Kronenberg Australia	20	832 1.4×	386 0.7×	285 0.8×	225 0.7×	314 1.3×	125	1.9k
Leena Laasonen Finland	26	433 0.7×	1.2k 2.3×	326 0.9×	261 0.8×	220 0.9×	83	2.4k
Toshihiko Hidaka Japan	21	345 0.6×	671 1.3×	181 0.5×	439 1.3×	132 0.5×	79	1.4k
J O'donnell New Zealand	27	255 0.4×	731 1.4×	261 0.7×	380 1.1×	255 1.0×	62	1.8k
K.A. Rickard Australia	19	881 1.4×	387 0.7×	239 0.6×	393 1.1×	211 0.9×	68	1.8k
A M Boerbooms Netherlands	24	273 0.4×	834 1.6×	217 0.6×	363 1.0×	160 0.6×	59	1.8k
Taeko Ishii Japan	18	440 0.7×	1.0k 2.0×	335 0.9×	629 1.8×	243 1.0×	54	2.0k
H. Terence Cook United Kingdom	22	236 0.4×	704 1.4×	370 1.0×	824 2.4×	161 0.7×	45	2.3k

Countries citing papers authored by Katsuyasu Saigo

Since Specialization

Citations

This map shows the geographic impact of Katsuyasu Saigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuyasu Saigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuyasu Saigo more than expected).

Fields of papers citing papers by Katsuyasu Saigo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuyasu Saigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuyasu Saigo. The network helps show where Katsuyasu Saigo may publish in the future.

Co-authorship network of co-authors of Katsuyasu Saigo

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuyasu Saigo. A scholar is included among the top collaborators of Katsuyasu Saigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuyasu Saigo. Katsuyasu Saigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saigo, Katsuyasu, et al.. (2024). Fluvastatin suppresses hemin-induced cell death, reactive oxygen species generation, and elevated labile iron pool. Hematology Transfusion and Cell Therapy. 46. S284–S290. 1 indexed citations

Hashimoto, Makoto, et al.. (2012). CHANGE IN THE RATE OF POST-TRANSFUSION-TRANSMITTED INFECTION TEST ADMINISTRATION FOLLOWING BY INTRODUCTION OF AN ALERT SYSTEM IN AN ELECTRONIC MEDICAL RECORD. Japanese Journal of Transfusion and Cell Therapy. 58(4). 547–551. 2 indexed citations

Yamaoka, Genji, Yoshiyuki Kubota, Tsutomu Nomura, et al.. (2010). The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation. International Journal of Laboratory Hematology. 32(6p1). e208–16. 28 indexed citations

Saigo, Katsuyasu, Mariko Takenokuchi, Akihiko Nishizawa, et al.. (2009). Usefulness of Immature Platelet Fraction for the Clinical Evaluation of Myelodysplastic Syndromes. PubMed. 15(2). 13–16. 9 indexed citations

Saigo, Katsuyasu, et al.. (2009). IMMATURE PLATELET FRACTION MEASURED USING THE AUTOMATED HEMATOLOGY ANALYZER XE-2100: A POSSIBLE PREDICTIVE MARKER FOR PLATELET RECOVERY AFTER CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION. Japanese Journal of Transfusion and Cell Therapy. 55(6). 691–697. 1 indexed citations

Saigo, Katsuyasu, et al.. (2009). TWO CASES OF CEREBRAL VESSEL DISEASE FOLLOWING HIGH DOSE INTRAVASCULAR IMMUNOGLOBULIN THERAPY. Japanese Journal of Transfusion and Cell Therapy. 55(5). 617–623.

Nomura, Shosaku�, Yoshiyuki Kurata, Yoshiaki Tomiyama, et al.. (2009). Effects of Bisphosphonate Administration on the Bone Mass in Immune Thrombocytopenic Purpura Patients Under Treatment With Steroids. Clinical and Applied Thrombosis/Hemostasis. 16(6). 622–627. 9 indexed citations

Kawamura, Kouichi, Yukihiro Tokumine, Nobukazu Araki, et al.. (2009). Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay. Transfusion Medicine. 20(2). 95–103. 8 indexed citations

Tatsumi, E, Mariko Takenokuchi, Yuji Nakamachi, et al.. (2006). HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expression. Leukemia Research. 31(7). 921–929. 16 indexed citations

10.

Imoto, Shion, Tohru Murayama, Kenichi Nagai, et al.. (2005). Usefulness of Sequential Automated Analysis of Fragmented Red Blood Cells for the Differential Diagnosis of Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome following Allogeneic Hematopoietic Cell Transplantation. PubMed. 11(2). 131–136. 4 indexed citations

11.

Saigo, Katsuyasu, Shinichi Kondo, Akiharu Okamura, et al.. (2005). Rituximab combined with a small dose of melphalan for a refractory follicular lymphoma patient. Leukemia & lymphoma. 47(2). 353–356. 1 indexed citations

12.

Sugimoto, T, et al.. (2001). Tetrasomy 21 as the sole acquired karyotypic abnormality in acute myeloblastic leukemia. Cancer Genetics and Cytogenetics. 128(2). 158–160. 2 indexed citations

13.

Nomura, Tsutomu, et al.. (2001). Evaluation of the optimal condition of blood sampling applied to the IMI (Immature Information) scattergram of the automated hematology analyzer SE-9000.. Journal of the Japan Society of Blood Transfusion. 47(4). 639–645. 2 indexed citations

14.

Saigo, Katsuyasu, et al.. (1999). Therapeutic strategy for post-transfusion graft-vs.-host disease.. PubMed. 69(3). 147–51. 5 indexed citations

15.

Shimazaki, Chihiro, Kazuho Shimura, Akio Okamoto, et al.. (1999). B‐cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. British Journal of Haematology. 104(4). 672–679. 62 indexed citations

16.

Taniguchi, Hirokazu, et al.. (1994). Extramedullary tumor as presentation of leukemia: Establishment of a new human GPIIb- and GPIIIa-positive leukemia cell line. Annals of Hematology. 68(3). 145–151. 3 indexed citations

17.

Ryo, Ryukichi, Wataru Sugano, Katsuyasu Saigo, et al.. (1992). Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen‐induced platelet aggregation. American Journal of Hematology. 39(1). 25–31. 76 indexed citations

18.

Ryo, Ryukichi, et al.. (1992). Megakaryocytic Leukemia and Platelet Factor 4. Leukemia & lymphoma. 8(4-5). 327–336. 1 indexed citations

19.

Saigo, Katsuyasu, et al.. (1990). Histidine‐rich glycoprotein as a negative acute phase reactant. American Journal of Hematology. 34(2). 149–150. 31 indexed citations

20.

Saigo, Katsuyasu, Shunichi Shiozawa, Kazuko Shiozawa, et al.. (1988). Alpha-interferon treatment for adult T cell leukemia: low levels of circulating alpha-interferon and it's clinical effectiveness. Annals of Hematology. 56(2). 83–86. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact